Martin Currie’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$44.1M Buy
82,254
+3,039
+4% +$1.45M 1.69% 20
2025
Q1
$33.3M Buy
79,215
+6,272
+9% +$2.72M 1.34% 25
2024
Q4
$30.2M Sell
72,943
-27,481
-27% -$12.1M 1.11% 28
2024
Q3
$48M Sell
100,424
-8,504
-8% -$4.13M 1.7% 21
2024
Q2
$53.1M Buy
108,928
+13,403
+14% +$6.73M 1.9% 18
2024
Q1
$51.6M Buy
95,525
+1,322
+1% +$722K 1.59% 23
2023
Q4
$52.3M Buy
+94,203
New +$44.2M 1.72% 22

Other funds holding IDXX

Martin Currie's IDXX Position: Q2 2025 in Review

Martin Currie increased its Idexx Laboratories (IDXX) stake by 3.8% in Q2 2025, buying an estimated $1.45M and bringing the position to 82,254 shares worth $44.1M. The position accounts for 1.69% of the portfolio, ranked #20.

Martin Currie first reported a position in IDXX in Q4 2023 and has held it in 7 quarters since. The position peaked at $53.1M in Q2 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Martin Currie held 82,254 shares of Idexx Laboratories worth $44.1M as of Q2 2025.
  • Martin Currie bought 3,039 Idexx Laboratories shares in Q2 2025, an estimated $1.45M.
  • Idexx Laboratories made up 1.69% of Martin Currie's portfolio in Q2 2025, its #20 holding.
  • Martin Currie first reported a position in Idexx Laboratories in Q4 2023 and has held it in 7 quarters since.
  • Martin Currie's Idexx Laboratories position peaked at $53.1M in Q2 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Martin Currie's 13F filing for Q2 2025, filed 12 Aug 2025.